NinePointTwo Capital
- SEC CIK
- 0001824516
- Latest filing
- Feb 14, 2024
ABCL holding history
AbCellera Biologics Inc. in every 13F filed by NinePointTwo Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABCL overviewAll 13F holders of ABCLFull Q4 2023 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −40,651−100.0% | Sold out | Holders |
| Q2 2023 | 40,651 | $262.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 40,651 | $306.0K | 0.1% | +25,254+164.0% | Added | Holders |
| Q4 2022 | 15,397 | $155.0K | 0.1% | −18,417−54.5% | Reduced | Holders |
| Q3 2022 | 33,814 | $334.0K | 0.1% | −20,913−38.2% | Reduced | Holders |
| Q2 2022 | 54,727 | $582.0K | 0.2% | +54,727 | New | Holders |